QurAlis to Participate in Upcoming Investor Conferences in March
CAMBRIDGE, Mass., Feb. 24, 2025 /PRNewswire/ -- QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of


